SOX30 and colorectal carcinoma: Therefore, the purpose of this present study was to explore the correlation of SOX30 expression measured by both immunohistochemistry (IHC) and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) with clinicopathological features and long-term prognosis in CRC patients.